GENUINE PARTS CO (GPC) earnings date, results and what the price requires
NYSE · SEC CIK 0000040987 · SEC filings checked Oct 16, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 21, 2026 | $6.54B | $227.6M | $1.65 | Filing |
| Mar 31, 2026 | Apr 21, 2026 | $6.26B | $188.5M | $1.37 | Filing |
| Dec 31, 2025 | Feb 17, 2026 | $6.01B | $-609.5M | $-4.38 | Filing |
| Sep 30, 2025 | Oct 21, 2025 | $6.26B | $226.2M | $1.62 | Filing |
| Jun 30, 2025 | Jul 22, 2025 | $6.16B | $254.9M | $1.83 | Filing |
| Mar 31, 2025 | Apr 22, 2025 | $5.87B | $194.4M | $1.40 | Filing |
| Dec 31, 2024 | Feb 18, 2025 | $5.77B | $133.1M | $0.96 | Filing |
| Sep 30, 2024 | Oct 22, 2024 | $5.97B | $226.6M | $1.62 | Filing |
What would GENUINE PARTS CO have to report for its valuation to change?
At $133.51, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 113.0% a year, to $11.41. On that path the next quarter needs diluted EPS near $3.45, against $1.62 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 113.0% | 113.0% |
| EPS needed in final year | $11.41 | $11.41 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. GPC goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.